ZEISS Medical Ecosystem - Digital Solutions Roll-out
Medical Technology is a deeply integrated core business
for the ZEISS Group
Medical Technology
Shareholder structure
of Carl Zeiss Meditec AG
41%
ZEISS
59%
Free float
ZEISS Group
Carl Zeiss Foundation
Heidenheim/Jena, Germany
100%
Carl Zeiss AG
Oberkochen, Germany
2021/22: € 8.8bn revenue
Industrial Quality &
Research
Semiconductor
Manufacturing
Technology
Consumer Markets
ZEISS
Shared Services
across the Zeiss Group
Corporate Services
(e.g. Treasury, Legal)
Basic R&D
Manufacturing
Sales & Service Companies
■
Carl Zeiss Foundation created in 1889 as sole stakeholder of Carl Zeiss AG. Statutory goal to promote natural science, engineering.
Envisioned close partnership of industry and science.
Areas of business for foundation company Carl Zeiss AG defined as optics, fine mechanics and optoelectronics.
Commitment to sustainability: safeguarding the future by responsible management, fulfilling special responsibility toward employees
and society.
Carl Zeiss Meditec AG formally created in 2002 through merger of ZEISS Ophthalmic business with listed laser technology maker
Asclepion Meditec AG (AFX) and strengthened by acquisition of Carl Zeiss' Surgical business in 2006.
Page 31View entire presentation